Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men

European Journal of Epidemiology

Volumn 31, Issue 9, 2016, Pages 853-865

  Liu, Junxiu ^a   Liu, Shiwei ^b,d   Zhou, Haiming ^c   Hanson, Timothy ^a   Yang, Ling ^d   Chen, Zhengming ^d   Zhou, Maigeng ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NORTHERN ILLINOIS UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alcohol drinking; Cancer; Cardiovascular disease; Green tea consumption; Mortality; Smoking

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHINESE; DIASTOLIC BLOOD PRESSURE; DRINKING BEHAVIOR; EATING HABIT; EDUCATION; EGG; FISH MEAT; FOLLOW UP; HERBAL TEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK; MORTALITY RISK; NEOPLASM; POULTRY MEAT; PROSPECTIVE STUDY; RISK REDUCTION; RURAL POPULATION; SMOKING; SYSTOLIC BLOOD PRESSURE; TEA; URBAN AREA; URBAN POPULATION; CHINA; DIET; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK;

ADULT; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; CHINA; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIET; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SMOKING; SURVEYS AND QUESTIONNAIRES; TEA;

EID: 84976515987     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-016-0173-3     Document Type: Article

References (55)

1. Hayat K, Iqbal H, Malik U, Bilal U, Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2013;55(7):939–54.
2. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21:334–50.
3. Tong X, Taylor AW, Giles L, Wittert GA, Shi Z. Tea consumption is inversely related to 5-year blood pressure change among adults in Jiangsu, China: a cross-sectional study. Nutr J. 2014;13:98.
4. http://www.teausa.com/teausa/images/Tea%20Fact%20Sheet%20FINAL.pdf.
5. http://www.uschina.usc.edu/w_usci/showarticle.aspx?articleID=17471&AspxAutoDetectCookieSupport=1.
6. Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein AM, Taylor PR. Jasmine tea consumption and upper gastrointestinal cancer in china. Cancer Causes Control. 2009;20:1997–2007.
7. http://www.tjpr.org/vol6_no3/638Sharma.pdf.
8. Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection (review). Int J Oncol. 2001;18:1307–13.
9. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;37:693–704.
10. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res. 2006;50:218–28.
11. Khan N, Mukhtar H. Tea and health: studies in humans. Curr Pharm Des. 2013;19:6141–7.
12. Blumberg JB. Introduction to the proceedings of the fifth international scientific symposium on tea and human health. Am J Clin Nutr. 2013;98:1607S–10S.
13. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr. 1996;50:28–32.
14. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003;163:1448–53.
15. Nagaya N, Yamamoto H, Uematsu M, Itoh T, Nakagawa K, Miyazawa T, Kangawa K, Miyatake K. Green tea reverses endothelial dysfunction in healthy smokers. Heart. 2004;90:1485–6.
16. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem. 2005;16:144–9.
17. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity. 2007;15:1473–83.
18. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004;164:1534–40.
19. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693–6.
20. Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J Exp Med. 1989;157:337–43.
21. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors. 2000;13:49–54.
22. Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, Okamoto M, Nose T. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12:191–8.
23. Suzuki E, Yorifuji T, Takao S, Komatsu H, Sugiyama M, Ohta T, Ishikawa-Takata K. Doi H Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol. 2009;19:732–9.
24. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, Group JS. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in japanese men and women. J Epidemiol Community Health. 2011;65:230–40.
25. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138:1548S–53S.
26. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in japan: the ohsaki study. JAMA. 2006;296:1255–65.
27. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, Beulens JW. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30:1665–71.
28. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2014;30(2):103–13.
29. Ruan R, Feng L, Li J, Ng TP, Zeng Y. Tea consumption and mortality in the oldest-old chinese. J Am Geriatr Soc. 2013;61:1937–42.
30. Ivey KL, Lewis JR, Prince RL, Hodgson JM. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br J Nutr. 2013;110:1648–55.
31. Qiu L, Sautter J, Gu D. Associations between frequency of tea consumption and health and mortality: evidence from old chinese. Br J Nutr. 2012;108:1686–97.
32. Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to ihd and stroke in the netherlands cohort study. Br J Nutr. 2010;104:1212–21.
33. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res. 2011;64:113–22.
34. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3:CD005004.
35. Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81.
36. Lambert JD. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr. 2013;98:1667S–75S.
37. Niu SR, Yang GH, Chen ZM, Wang JL, Wang GH, He XZ, Schoepff H, Boreham J, Pan HC, Peto R. Emerging tobacco hazards in china: 2. Early mortality results from a prospective study. BMJ. 1998;317:1423–4.
38. Saito E, Inoue M, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Noda M, Iso H, Tsugane S, Group JS. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan public health center-based prospective study (JPHC study). Ann Epidemiol. 2015;25:512–8.
39. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30:103–13.
40. Pang J, Zhang Z, Zheng TZ, Bassig BA, Mao C, Liu X, Zhu Y, Shi K, Ge J, Yang YJ, Dejia-Huang, Bai M, Peng Y. Green tea consumption and risk of cardiovascular and ischemic related diseases: a meta-analysis. Int J Cardiol. 2016;202:967–74. doi:10.1016/j.ijcard.2014.12.176.
41. Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114:673–83.
42. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a japanese population. Prev Med. 1997;26:769–75.
43. Nakachi K, Eguchi H, Imai K. Can teatime increase one’s lifetime? Ageing Res Rev. 2003;2:1–10.
44. Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143:1299–308.
45. Office ESCP. Cardiopulse: drinking tea reduces non-cardiovascular mortality by 24%. Eur Heart J. 2015;36:706–7.
46. Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol. 2009;83:11–21.
47. Huang WY, Lin YR, Ho RF, Liu HY, Lin YS. Effects of water solutions on extracting green tea leaves. Sci World J. 2013;2013:368350.
48. Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2014;24:823–36.
49. Senanayake SN. Green tea extract: chemistry, antioxidant properties and food applications—a review. J Funct Foods. 2013;5:1529–41.
50. Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician. 2009;79:591–4.
51. Lin D, Tu Y, Zhu L. Concentrations and health risk of polycyclic aromatic hydrocarbons in tea. Food Chem Toxicol. 2005;43:41–8.
52. Schwalfenberg G, Genuis SJ, Rodushkin I. The benefits and risks of consuming brewed tea: beware of toxic element contamination. J Toxicol. 2013;2013:370460.
53. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, Westerholm R. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect. 2002;110(Suppl 3):451–88.
54. Ding YS, Yan XJ, Jain RB, Lopp E, Tavakoli A, Polzin GM, Stanfill SB, Ashley DL, Watson CH. Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from US Brand and non-US Brand cigarettes. Environ Sci Technol. 2006;40:1133–8.
55. Tithof PK, Elgayyar M, Cho Y, Guan W, Fisher AB, Peters-Golden M. Polycyclic aromatic hydrocarbons present in cigarette smoke cause endothelial cell apoptosis by a phospholipase A2-dependent mechanism. FASEB J. 2002;16:1463–4.